ArticleCureus2026
An Atypical Presentation of Cutaneous Angiosarcoma: A Diagnostic Challenge in an End-Stage Renal Disease Patient.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angiosarcomas are rare and highly aggressive malignant vascular tumors that are associated with a very poor prognosis. The rarity of the disease, its variable clinical presentations, and differing pathophysiologic mechanisms make diagnosing angiosarcoma a challenge. This case report details a 75-year-old woman with an atypical presentation of cutaneous angiosarcoma in the absence of traditional risk factors. Due to the patient's history of end-stage renal disease, her initial presentation was highly suspicious for cutaneous calciphylaxis of the left lower extremity. After a thorough workup, this patient likely had malignant transformation of her chronic venous insufficiency. This case underscores the necessity for healthcare providers to consider angiosarcoma in the differential diagnosis of atypical, persistent violaceous nodules and plaques, even in the absence of classic risk factors such as radiation exposure, chronic lymphedema, genetic syndromes, and certain linked carcinogens. A high index of suspicion, combined with timely diagnostic interventions, is vital to address this aggressive malignancy effectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.